Comparative study of ultrasound attenuation analysis and controlled attenuation parameter in the diagnosis and grading of liver steatosis in non-alcoholic fatty liver disease patients

[1] Zhou F(2019)Unexpected Rapid increase in the Burden of NAFLD in China from 2008 to 2018: a systematic review and Meta-analysis Hepatology (Baltimore MD) 70 1119-33

[2] Wang F-S(2014)The global burden of liver disease: the major impact of China Hepatology (Baltimore MD) 60 2099-108

[3] EASL-EASD AJ(2016)EASO Clinical Practice guidelines for the management of non-alcoholic fatty liver disease Obes Facts 9 65-90

[4] Sanyal G(2011)Endpoints and clinical trial design for nonalcoholic steatohepatitis Hepatology (Baltimore MD) 54 344-53

[5] Musso F(2011)Meta-analysis: natural history of non-alcoholic fatty liver disease (NAFLD) and diagnostic accuracy of non-invasive tests for liver disease severity Ann Med 43 617-49

[6] Piccinino A(1986)Complications following percutaneous liver biopsy. A multicentre retrospective study on 68,276 biopsies J Hepatol 2 165-73

[7] Regev R(2002)Sampling error and intraobserver variation in liver biopsy in patients with chronic HCV infection Am J Gastroenterol 97 2614-8

[8] Hernaez G(2011)Diagnostic accuracy and reliability of ultrasonography for the detection of fatty liver: a meta-analysis Hepatology (Baltimore MD) 54 1082-90

[9] Ferraioli AE(2019)Detection of liver steatosis with a Novel Ultrasound-based technique: a pilot study using MRI-Derived Proton Density Fat Fraction as the Gold Standard Clin Translational Gastroenterol 10 e00081-97

[10] Bohte SM(2011)The diagnostic accuracy of US, CT, MRI and 1H-MRS for the evaluation of hepatic steatosis compared with liver biopsy: a meta-analysis Eur Radiol 21 87-96

[1] Zhou F(2019)Unexpected Rapid increase in the Burden of NAFLD in China from 2008 to 2018: a systematic review and Meta-analysis Hepatology (Baltimore MD) 70 1119-33

[2] Wang F-S(2014)The global burden of liver disease: the major impact of China Hepatology (Baltimore MD) 60 2099-108

[3] EASL-EASD AJ(2016)EASO Clinical Practice guidelines for the management of non-alcoholic fatty liver disease Obes Facts 9 65-90

[4] Sanyal G(2011)Endpoints and clinical trial design for nonalcoholic steatohepatitis Hepatology (Baltimore MD) 54 344-53

[5] Musso F(2011)Meta-analysis: natural history of non-alcoholic fatty liver disease (NAFLD) and diagnostic accuracy of non-invasive tests for liver disease severity Ann Med 43 617-49

[6] Piccinino A(1986)Complications following percutaneous liver biopsy. A multicentre retrospective study on 68,276 biopsies J Hepatol 2 165-73

[7] Regev R(2002)Sampling error and intraobserver variation in liver biopsy in patients with chronic HCV infection Am J Gastroenterol 97 2614-8

[8] Hernaez G(2011)Diagnostic accuracy and reliability of ultrasonography for the detection of fatty liver: a meta-analysis Hepatology (Baltimore MD) 54 1082-90

[9] Ferraioli AE(2019)Detection of liver steatosis with a Novel Ultrasound-based technique: a pilot study using MRI-Derived Proton Density Fat Fraction as the Gold Standard Clin Translational Gastroenterol 10 e00081-97

[10] Bohte SM(2011)The diagnostic accuracy of US, CT, MRI and 1H-MRS for the evaluation of hepatic steatosis compared with liver biopsy: a meta-analysis Eur Radiol 21 87-96